Achilles Therapeutics Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	3.37	0.7	0.35
Short-Term Investments	0.02	-	0.01
Cash & Short-Term Investments	3.39	0.7	0.36
Cash Growth	385.77%	94.99%	-
Accounts Receivable	4.68	5.27	1.85
Receivables	7.31	5.27	1.85
Prepaid Expenses	0.01	0.08	0.01
Other Current Assets	0.03	-	-
Total Current Assets	10.73	6.05	2.21
Property, Plant & Equipment	0.39	0.3	0.4
Long-Term Investments	0.06	0.05	0.11
Long-Term Accounts Receivable	0.33	-	-
Long-Term Deferred Charges	-	0.32	-
Other Long-Term Assets	0.01	0.03	0.06
Total Assets	11.53	6.76	2.78
Accounts Payable	2.72	1.96	1.26
Accrued Expenses	0.3	0.22	0.3
Current Portion of Long-Term Debt	0.26	0.43	0.35
Current Portion of Leases	0.22	0.2	0.17
Current Income Taxes Payable	-	-	0.11
Current Unearned Revenue	-	-	0.14
Other Current Liabilities	0.5	0.55	0.43
Total Current Liabilities	4	3.36	2.75
Long-Term Debt	0.58	0.84	0.3
Long-Term Leases	0.18	0.12	0.24
Long-Term Deferred Tax Liabilities	0.39	0.58	0
Total Liabilities	5.15	4.89	3.3
Common Stock	0	0	0
Additional Paid-In Capital	6.29	1	1
Retained Earnings	-0.16	0.87	-1.52
Comprehensive Income & Other	0.25	-	-
Shareholders' Equity	6.38	1.87	-0.52
Total Liabilities & Equity	11.53	6.76	2.78
Total Debt	1.23	1.58	1.07
Net Cash (Debt)	2.16	-0.88	-0.71
Net Cash Per Share	0.11	-0.04	-0.04
Filing Date Shares Outstanding	21.5	20	20
Total Common Shares Outstanding	21.5	20	20
Working Capital	6.73	2.68	-0.54
Book Value Per Share	0.30	0.09	-0.03
Tangible Book Value	6.38	1.87	-0.52
Tangible Book Value Per Share	0.30	0.09	-0.03
Machinery	0.03	0.03	0.02

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q